跳至主要内容
临床试验/JPRN-jRCTs071180095
JPRN-jRCTs071180095招募中2 期

Efficacy and safety of pyrimethamine/sulfadiazine/folinate combination therapy for the treatment of disseminated toxoplasmosis and toxoplasma encephalitis - Treatment of disseminated toxoplasmosis/toxoplasma encephalitis with pyrimethamine/sulfadiazine

Maruyama Haruhiko0 个研究点目标入组 35 人开始时间: 2019年3月29日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
35

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 16age old 至 ot applicable(—)
性别
All

入选标准

  • Confirmed toxoplasmosis patients (DNA positive)
  • Suspected toxoplasmosis patients
  • #1 typical brain imaging
  • #2 serum anti-Toxoplasma IgG positive
  • #3 other diseases are excluded

排除标准

  • #1 HIV positive patients
  • #2 patients allergic to test compounds
  • #3 patients with megaloblastic anemia due to
  • folate deficiency
  • #4 No consent is given from the patient
  • him/herself nor a legally authorized
  • representative/guardian of the patient
  • #5 patients principal investigator judged
  • inappropriate

研究者

发起方
Maruyama Haruhiko

相似试验